Hospital
Shanghai Sixth People's Hospital上海市第六人民医院
At a glance
Published values only, each read from the record this page is built on. The listings behind them are in the section below.
-
Fudan University hospital rankings A+++ General list, 2023
-
National key clinical specialties 10 at evidence level A or B
-
Published research 17 PubMed records we hold for this hospital (the newest twenty per hospital)
-
Registered studies 3 records we hold for this hospital, as registered
Rankings & accreditation
These listings are published by the bodies that run them, not by this site. Every line carries the year it was published and a link to its source; this is not a paid or promoted listing.
Fudan University hospital rankings
| Item | Rank / tier | Year | Caliber | Source |
|---|---|---|---|---|
| General list | A+++ | 2023 | Tier only; hospitals in the same tier are not ordered against each other | https://rank.cn-healthcare.com/fudan/national-general |
Fudan specialty reputation ranking
| Item | Rank / tier | Year | Caliber | Source |
|---|---|---|---|---|
| Otorhinolaryngology 耳鼻喉科 | #7 | 2023 | Place in the specialty reputation ranking | https://www.fdygs.com/news2023-1.aspx |
National key clinical specialties
| Specialty | Evidence | Source |
|---|---|---|
| Orthopedics 关节外科 | Level B | https://www.6thhosp.com/content/news/11/vinfor |
| Endocrinology and Metabolism 内分泌代谢科 | Level B | https://www.6thhosp.com/content/news/11/vinfor |
| Trauma Surgery 创伤外科 | Level B | https://www.6thhosp.com/content/news/11/vinfor |
| Medical Imaging 医学影像科 | Level B | https://www.6thhosp.com/content/news/11/vinfor |
| Emergency Medicine 急诊医学科 | Level B | https://www.6thhosp.com/content/news/11/vinfor |
| Otorhinolaryngology 耳鼻咽喉科 | Level B | https://www.6thhosp.com/content/news/11/vinfor |
| Foot and Ankle Surgery 足踝外科 | Level B | https://www.6thhosp.com/content/news/11/vinfor |
| Orthopedics 运动医学科 | Level B | https://www.6thhosp.com/content/news/11/vinfor |
| Skull Base Surgery 颅底外科 | Level B | https://www.6thhosp.com/Content/News/9817 |
| Orthopedics 骨科 | Level B | https://www.6thhosp.com/content/news/11/vinfor |
Batch is not published by the source.
10 specialty rows, each carrying its own evidence level.
Each row carries its own evidence level and its own source. Level definitions are on the methodology page.
Values written in Chinese are quoted as published by the source.
Administrative grade
| Item | Rank / tier | Year | Caliber | Source |
|---|---|---|---|---|
| Grade as published Tier 3, class A general hospital (re-accredited) 三级甲等综合医院(复评) | Tier 3, class A | 2025-09-19 | An administrative designation, not a ranking; the date is the list's own publication date, not the year the grade was awarded | The source of this record, at the foot of this page |
Conditions treated here
Conditions this site files under the specialties above. It is a record of the listings, not a recommendation.
For international patients
A line appears here only where we hold a record for it. A line that is missing has not been verified - ask us and we will put the question to the hospital.
Hospital details
- Chinese name
- 上海市第六人民医院
- English name
- Shanghai Sixth People's Hospital
- Grade
- Tier 3, class A general hospital (re-accredited) 三级甲等综合医院(复评)
- Grade list as published
- 2025-09-19
Values written in Chinese are quoted as published by the source.
The grade list reference is the date or review batch the official list was published under; it is quoted in the source's language.
Evidence for this condition
Selected using official public data sources
-
Colorectal cancer
Published research
- Prognostic value of lncRNA DARS-AS1 in colorectal cancer and its regulatory effect on tumor progression. BMC gastroenterology, 2026
- Systemic inflammation mediates the link between metabolic syndrome and colorectal cancer risk: insights from a large prospective cohort. Postgraduate medical journal, 2026
3 more published studies
PubMed indexes 5 papers on this condition that name this hospital.
Also ranked: Otorhinolaryngology #7 in the Fudan list.
-
Breast cancer
Published research
- Natural Product-Based Nanomedicine in the Treatment of Breast Cancer. Pharmaceutics, 2026
- RHAMM drives formation of polyploid cancer cells and confers resistance to ER-targeted therapy in breast cancer. Proceedings of the National Academy of Sciences of the United States of America, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Otorhinolaryngology #7 in the Fudan list.
-
Lung cancer
Published research
- Global inequalities in tracheal, bronchus, and lung cancer care quality from 1990 to 2021. iScience, 2026
- Precisely Engineered Block Copolymers for Efficient PTEN mRNA Therapy of Non-Small Cell Lung Cancer. ACS applied materials & interfaces, 2026
1 more published study
PubMed indexes 3 papers on this condition that name this hospital.
Also ranked: Otorhinolaryngology #7 in the Fudan list.
-
Liver cancer
Published research
- Development of a PNI-Based Prognostic Model for Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib-Based Triple Therapy. Journal of hepatocellular carcinoma, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Otorhinolaryngology #7 in the Fudan list.
-
Stomach cancer
Published research
- Correction to: Agmatinase Facilitates Gastric Cancer Tumorigenesis Through PI3K/AKT-Mediated Enhancement of Proliferation, Invasion, and Stemness. Applied biochemistry and biotechnology, 2026
- Agmatinase Facilitates Gastric Cancer Tumorigenesis Through PI3K/AKT-Mediated Enhancement of Proliferation, Invasion, and Stemness. Applied biochemistry and biotechnology, 2026
1 more published study
PubMed indexes 3 papers on this condition that name this hospital.
Also ranked: Otorhinolaryngology #7 in the Fudan list.
-
Prostate cancer
Published research
- Neddylation-triggered ubiquitination and proteasomal degradation of HELLS inhibits prostate cancer growth via genomic instability. Biochimica et biophysica acta. Molecular basis of disease, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Otorhinolaryngology #7 in the Fudan list.
-
Thyroid cancer
Published research
- Proteomic analysis reveals modulation of key proteins in follicular thyroid cancer progression. Chinese medical journal, 2026
- Antitumor and resensitizing effects of wogonin in thyroid cancer via PDGFRB-dependent mechanisms. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Otorhinolaryngology #7 in the Fudan list.
-
Nasopharyngeal carcinoma
Fudan specialty reputation ranking 2023
- Otorhinolaryngology #7 https://www.fdygs.com/news2023-1.aspx
National key clinical specialty
- Otorhinolaryngology (level B) https://www.6thhosp.com/content/news/11/vinfor
-
Hip and knee replacement
National key clinical specialty
- Orthopedics (level B) https://www.6thhosp.com/content/news/11/vinfor
- Orthopedics (level B) https://www.6thhosp.com/content/news/11/vinfor
- Orthopedics (level B) https://www.6thhosp.com/content/news/11/vinfor
Also ranked: Otorhinolaryngology #7 in the Fudan list.
-
Bone and soft tissue sarcoma
National key clinical specialty
- Orthopedics (level B) https://www.6thhosp.com/content/news/11/vinfor
- Orthopedics (level B) https://www.6thhosp.com/content/news/11/vinfor
- Orthopedics (level B) https://www.6thhosp.com/content/news/11/vinfor
Also ranked: Otorhinolaryngology #7 in the Fudan list.
Other hospitals in Shanghai
Source & evidence
- Source URL
- https://rank.cn-healthcare.com/fudan/national-general
- Source scheme
- https
- Source type
- Third-party compilation
- Evidence level
- B - hospital self-statement or authoritative media
- Retrieved on
- 2026-09-24